Clinical Trials

Can Diverse Clinical Trials Restore Trust in Minority Communities?
Research & Development Can Diverse Clinical Trials Restore Trust in Minority Communities?

The healthcare system's history of unethical practices and ongoing issues has fostered a deep mistrust among minority communities. This mistrust affects everything from routine healthcare appointments to participation in clinical trials. Despite significant efforts to increase diversity, enrollment

Can Treg Therapy by PolTREG Revolutionize Type-1 Diabetes Treatment?
Research & Development Can Treg Therapy by PolTREG Revolutionize Type-1 Diabetes Treatment?

Recent clinical advancements by PolTREG, a pioneering Polish biotechnology company, have cast a hopeful light on the treatment of type-1 diabetes (T1D). The company's breakthrough Treg therapy, PTG-007, has shown great promise in fundamentally altering the management of this autoimmune disease. T1D

Can WVE-003 Reform Huntington’s Treatment With Biomarker Innovations?
Research & Development Can WVE-003 Reform Huntington’s Treatment With Biomarker Innovations?

Huntington’s disease, a genetic disorder that leads to the gradual death of nerve cells in the brain, has long challenged the medical and scientific communities. Traditional treatments have provided only limited symptom relief, pushing the quest for innovative therapies that can alter the disease’s

Auxilius Raises $10M to Transform Clinical Trial Financial Management
Research & Development Auxilius Raises $10M to Transform Clinical Trial Financial Management

Auxilius, a company specializing in Clinical Trial Financial Management (CTFM) software for the biopharma industry, has recently raised $10 million in financing led by SignalFire. With an astounding 800% year-over-year growth in annual recurring revenue (ARR) for 2023, this upsurge underscores the

Spur Therapeutics Pioneers Gene Therapy with New Focus on Chronic Diseases
Research & Development Spur Therapeutics Pioneers Gene Therapy with New Focus on Chronic Diseases

Spur Therapeutics, previously known as Freeline Therapeutics, is making waves in the field of genetic medicine with its rebranding and renewed mission to revolutionize the treatment of chronic diseases through gene therapy. The company's ambitious initiatives encompass innovative research,

Spur Therapeutics Expands Gene Therapy Horizons with Strategic Rebranding
Research & Development Spur Therapeutics Expands Gene Therapy Horizons with Strategic Rebranding

Freeline Therapeutics, known for its pioneering work in gene therapy, has unveiled a new identity and an expanded mission, rebranding itself as Spur Therapeutics. This transformation marks a significant step towards a broader and more ambitious vision that includes tackling both rare genetic

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later